default author photo

Fiona Miall

University Hospitals of Leicester NHS Trust - Department of Haematology

SCHOLARLY PAPERS

1

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Triplet Combination of Polatuzumab Vedotin with Rituximab and Lenalidomide in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Number of pages: 28 Posted: 28 Aug 2023
Pau Abrisqueta, Eva Gonzàlez-Barca, Carlos Panizo, José María Arguiñano Pérez, Fiona Miall, Mariana Bastos-Oreiro, Ana Triguero, Lalita Banerjee, Andrew K. McMillan, Erlene Seymour, Jamie Hirata, Lisa Musick, Sunil Sharma, Hyun Yong Jin, Jayson de Guzman and Catherine Diefenbach
Hospital Vall D’Hebron, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Universitario Donostia, Complejo Hospitalario de Navarra, University Hospitals of Leicester NHS Trust - Department of Haematology, Hospital General Universitario Gregorio Marañon, Hospital Clínic de Barcelona - Department of Haematology, Maidstone and Tunbridge Wells NHS Trust - Oncology Centre, Nottingham University Hospitals NHS Trust - Centre for Clinical Haematology, Wayne State University - Karmanos Cancer Institute, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Syneos Health, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and New York University (NYU) - Laura and Isaac Perlmutter Cancer Center
Downloads 82 (796,622)

Abstract:

Loading...

Relapsed/Refractory DLBCL, Non-Hodgkin Lymphoma, Polatuzumab Vedotin, Lenalidomide, Circulating Tumour DNA